Pharmacology in Anesthesia Practice

Contributors ; 1 Inhalational Agents ; 1.1 Volatile Anesthetics ; Philip Gallegos, MD, Nina Singh-Radcliff, MD ; 1.2 Nitrous Oxide ; Philip Gallegos, MD and Nina Singh-Radcliff, MD ; 2 Induction Agents ; 2.1 Propofol ; Ellen Wang, MD and Nina Singh-Radcliff, MD ; 2.2 Barbiturates ; Katherine C. Normand, MD ; 3 Pain Medications ; 3.1 Opioids ; Thomas H. Scott and Jane C. Ballantyne ; 3.2 Skeletal Muscle Relaxants ; Chitra Ramasubbu, MD, Anita Gupta DO, PharmD ; 3.3 Non-Steroidal Anti-Inflammatory Drugs ; Matthew Lesneski MD and Peter Yi MD ; 3.4 Acetaminophen ; Chitra Ramasubbu, MD and Anita Gupta DO, PharmD ; 3.5 Benzodiazepines ; Ellen Wang, MD ; 4 Muscle Relaxants ; 4.1 Nondepolarizing Neuromuscular Blockers ; Jared Feinman, MD and Nina Singh-Radcliff, MD ; 4.2 Succinylcholine ; Jared Feinman, MD and Nina Singh-Radcliff, MD ; 5 Anticholinergics and Anticholinesterases ; 5.1 Anticholinesterases ; Devin Tang, MD and Anita Gupta, DO PharmD ; 5.2 Anticholinergics ; Anita Gupta DO, PharmD, Amna Mehdi, BS ; 6 Vasopressors and Inotropes ; Priscilla Nelson, MD, Jonas A. Nelson, MD, and Nina Singh-Radcliff, MD ; 7 Anti-Hypertensives ; 7.1 Beta Blockers ; Anita Gupta DO, PharmD, and Amna Mehdi, BS ; 7.2 Antihypertensives ; Onyi Onuoha, MD and Nina Singh-Radcliff, MD ; 8 Local Anesthetics ; Nina Singh-Radcliff, MD ; 9 Antiemetics ; Alissa Wilmot, MD and Sander Schlichter, MD ; 10 Gastric Medications ; Shanique Brown, MD, and Nina Singh-Radcliff, MD ; 11 Anti-Inflammatory ; 11.1 Steroids ; Lisa Witkin, MD, Anita Gupta, DO, PharmD ; 11.2 Antihistamines ; Mona Patel, MD, and Anita Gupta, DO, PharmD ; 12 Narcotic and Benzodiazepine Reversal Agents ; Gaurav Bhatia, MD, and Anita Gupta, DO, PharmD ; 13 Hematologic Agents ; 13.1 Dipyridamole ; Elizabeth Duggan, MD ; 13.2 Adenosine Diphosphate Inhibitors ; Michael J. Duggan, MD, Elizabeth W. Duggan, and Jiri Horak, MD ; 13.3 Low Molecular Weight Heparin (LMWH) ; Elizabeth W. Duggan, MD, Michael J. Duggan, MD, and Maurizio Cereda, MD ; 13.4 Miscellaneous Anticoagulants ; Michael J. Duggan, MD, Elizabeth W. Duggan, and Jiri Horak, MD ; 13.5 Streptokinase and Tissue Plasminogen Activator (tPA) ; Elizabeth Duggan, MD and Michael Duggan, MD ; 13.6 Heparin and Argatroban ; Crystal C. Wright, MD ; 13.7 Procoagulants ; Peter Killoran, MD, and Katherine Normand, MD ; 14 Obstetrics ; 14.1 Prostaglandins (carboprost, misoprostol, alprostadil) ; Cristianna Vallera, MD ; 14.2 Ergots (Methylergonovine Maleate) ; Emily Baird, MD ; 14.3 Oxytocin (Pitocin) ; Emily Baird, MD ; 14.4 Magnesium ; Robert Gaiser, MD ; 14.5 Beta 2 Adrenergic Agonist (Terbutaline) ; Robert Gaiser, MD ; 15 Antiepileptic Drugs ; Emily E. Peoples, M.D. ; 16 Bronchodilators ; Anita Gupta DO, PharmD, and Amna Mehdi, BS ; 17 IV Fluids ; 17.1 Crystalloids ; Katherine Chuy, MD, and Nina Singh-Radcliff, MD ; 17.2 Colloids ; Katherine Chuy, MD, and Nina Singh-Radcliff, MD ; 17.3 Transfusion Products ; Nina Singh Radcliff, MD ; 18 Electrolytes ; 18.1 Sodium/Potassium/Calcium/Phosphate ; Yianni Augoustides and Tygh Wyckoff ; 18.2 Sodium bicarbonate ; Nina Singh-Radcliff, MD ; 19 Diuretics ; 20 Antiarrhythmics ; 20.1 Antiarrhythmics ; Gaurav Malhotra, MD ; 21 Antihyperglycemic Agents ; 21.1 Insulin ; Elizabeth Valentine, MD and Nina Singh-Radcliff, MD ; 22 Mood Stabilizers and Antidepressants ; 22.1 Monoamine Oxidase Inhibitors (MAOIs) ; Gregory Moy, MD and Nabil Elkassabany, MD ; 22.2 Selective Serotonin Reuptake Inhibitors (SSRIs) ; Gregory Moy, MD and Nabil Elkassabany, MD ; 22.3 Tricyclic Antidepressants (TCAs) ; Gregory Moy, MD, and Nabil Elkassabany, MD ; 22.4 Antipsychotics ; Gregory Moy, MD, and Nabil Elkassabany, MD ; 22.5 Lithium ; Gregory Moy, MD and Nabil Elkassabany, MD ; 23 Antibiotics ; 23.1 Antibiotics ; Nina Singh-Radcliff MD and Kris E. Radcliff, MD ; 23.2 Antivirals ; Meghan Lane-Fall, MD and Todd Miano, PharmD, BCPS ; 24 Statins: HMG-CoA Reductase Inhibitors ; Jason Choi, MD, and John G. Augoustides, MD ; 25 Vitamins/Herbals ; Ellen Wang, MD ; 26 Illicit Substances ; 26.1 Cocaine ; Nabil Elkassabany, MD ; 26.2 Drugs of Abuse ; William Gao and Nabil Elkassabany ; 27 Other Key Drugs ; 27.1 1-deamino-8-D-arginine vasopressin (DDAVP) ; Jesse Raiten, MD ; 27.2 Carbidopa ; Shannon Bianchi, MD and Nina Singh-Radcliff, MD ; 27.3 Doxapram ; Shannon Bianchi, MD ; 27.4 Caffeine ; Shannon Bianchi, MD ; 27.5 Nitric oxide ; Jesse Raiten, MD ; 27.6 Dexmedetomidine ; Shannon Bianchi, MD ; 27.7 Acetylcysteine ; Shannon Bianchi, MD ; 27.8 Adriamycin (Doxorubicin) ; Matt N. Decker and Nina Singh-Radcliff, MD ; 27.9 Sugammedex ; Mark Decker, MD, and Nina Singh-Radcliff, MD ; 27.10 Thyroid Medications ; Mona Patel, MD, Anita Gupta, DO, PharmD